Apixaban Impurity 91 | CAS 2456339-94-7 - Request Quote
Apixaban Impurity 91
| SZ CAT No: | SZ-A062126 |
| CAS No | 2456339-94-7 |
| Mol.F. | C15H19N3O4 |
| Mol.Wt. | 305.3 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apixaban Impurity 91 is chemically 3-Morpholino-1-(4-nitrophenyl)piperidin-2-one. Apixaban Impurity 91 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 91 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2456339-94-7
Purchase 2456339-94-7
Order 2456339-94-7
Enquire 2456339-94-7
price of 2456339-94-7
2456339-94-7 Supplier
2456339-94-7 Manufacturer
2456339-94-7 Exporter
buy high quality Apixaban Impurity 91
Purchase Apixaban Impurity 91
Apixaban Impurity 91 suppliers
Apixaban Impurity 91 manufacturers
Apixaban Impurity 91 price
Order Apixaban Impurity 91
Enquire Apixaban Impurity 91
Apixaban Impurity 91 cost
Apixaban Impurity 91 Supplier
Apixaban Impurity 91 Distributor
Apixaban Impurity 91 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 91 for ANDA Filing
Apixaban Impurity 91 for Forced Degradation Studies
Apixaban Impurity 91 Identification Standards
Apixaban Impurity 91 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.